Literature DB >> 33478509

Risk factors for rapid progressive neurological deterioration in patients with cervical spondylotic myelopathy.

Weiyang Zhong1, Lin Wang1, Tianji Huang1, Xiaoji Luo2.   

Abstract

BACKGROUND: The rapid progressive cervical spondylotic myelopathy (rp-CSM) which had a course of CSM less than 1 month and suffered rapidly progressive neurological deterioration had few reports. Therefore, it is important for us to recognize the pathophysiology of CSM especially the rp-CSM. The study aimed to investigate the risk factors for rapidly progressive (rp) neurological deterioration in patients with cervical spondylotic myelopathy (CSM).
METHODS: A total of 159 patients were reviewed and divided into an rp-CSM group and a chronic-CSM (c-CSM) group. Various clinical indexes, including age, sex, Japanese Orthopaedic Association (JOA) score, intramedullary MR T2-hyperintensity, congenital/degenerative spinal stenosis, and local type of ossification of the posterior longitudinal ligament (OPLL), were analyzed, and independent risk factors were investigated.
RESULTS: Thirty-four of 159 patients (21.4%) were diagnosed with rp-CSM. All patients were followed up for a mean of 68.56 ± 14.00 months in the rp-CSM group and 62.66 ± 19.95 months in the c-CSM group. No significant difference was found in sex, mean age, smoking and drinking status, diabetes mellitus (DM), hypertension, surgery time, blood loss, JOA score, degenerative spinal stenosis, or OPLL (local). Univariate analyses demonstrated that rp-CSM patients tended to have MR T2-hyperintensity, longer hospital stay, shorter waiting time for surgery, more congenital spinal stenosis, and worse neurological function and to prefer more posterior surgeries than c-CSM patients. A multiple logistic regression analysis showed that congenital spinal stenosis and MR T2-hyperintensity were independently related to the presence of rp-CSM.
CONCLUSIONS: MR T2-hyperintensity and congenital spinal stenosis were risk factors for rp-CSM. Although neurological function deteriorates rapidly, early surgical decompression is recommended and can achieve good neurological recovery after surgery, indicating that rp-CSM could be a reversible condition.

Entities:  

Keywords:  Cervical spondylotic myelopathy,; MR T2-hyperintensity; Risk factor,

Mesh:

Year:  2021        PMID: 33478509      PMCID: PMC7818545          DOI: 10.1186/s13018-021-02227-6

Source DB:  PubMed          Journal:  J Orthop Surg Res        ISSN: 1749-799X            Impact factor:   2.359


  18 in total

1.  Risk Factors for Rapidly Progressive Neurological Deterioration in Cervical Spondylotic Myelopathy.

Authors:  Eiji Takasawa; Yasunori Sorimachi; Yoichi Iizuka; Daisuke Tsunoda; Tokue Mieda; Haku Iizuka; Hirotaka Chikuda
Journal:  Spine (Phila Pa 1976)       Date:  2019-06-15       Impact factor: 3.468

Review 2.  Anterior approach versus posterior approach for the treatment of multilevel cervical spondylotic myelopathy: a systemic review and meta-analysis.

Authors:  Bin Zhu; Yilan Xu; Xiaoguang Liu; Zhongjun Liu; Gengting Dang
Journal:  Eur Spine J       Date:  2013-05-09       Impact factor: 3.134

Review 3.  Comparison of anterior approach versus posterior approach for the treatment of multilevel cervical spondylotic myelopathy.

Authors:  Jiaquan Luo; Kai Cao; Sheng Huang; Liangping Li; Ting Yu; Cong Cao; Rui Zhong; Ming Gong; Zhiyu Zhou; Xuenong Zou
Journal:  Eur Spine J       Date:  2015-04-04       Impact factor: 3.134

4.  The effect of nimodipine and dextran on axonal function and blood flow following experimental spinal cord injury.

Authors:  M G Fehlings; C H Tator; R D Linden
Journal:  J Neurosurg       Date:  1989-09       Impact factor: 5.115

5.  Cervical spondylotic myelopathy surgical trial: randomized, controlled trial design and rationale.

Authors:  Zoher Ghogawala; Edward C Benzel; Robert F Heary; K Daniel Riew; Todd J Albert; William E Butler; Fred G Barker; John G Heller; Paul C McCormick; Robert G Whitmore; Karen M Freund; J Sanford Schwartz
Journal:  Neurosurgery       Date:  2014-10       Impact factor: 4.654

6.  Epidemiology of cervical spondylotic myelopathy and its risk of causing spinal cord injury: a national cohort study.

Authors:  Jau-Ching Wu; Chin-Chu Ko; Yu-Shu Yen; Wen-Cheng Huang; Yu-Chun Chen; Laura Liu; Tsung-Hsi Tu; Su-Shun Lo; Henrich Cheng
Journal:  Neurosurg Focus       Date:  2013-07       Impact factor: 4.047

7.  The natural history of cervical spondylotic myelopathy.

Authors:  K K Sadasivan; R P Reddy; J A Albright
Journal:  Yale J Biol Med       Date:  1993 May-Jun

8.  Surgical approaches and outcomes for cervical myelopathy with increased signal intensity on T2-weighted MRI: a meta-analysis.

Authors:  Yuan Xu; Feng Chen; Yipeng Wang; Jianguo Zhang; Jianhua Hu
Journal:  J Orthop Surg Res       Date:  2019-07-18       Impact factor: 2.359

Review 9.  Laminoplasty versus laminectomy for multi-level cervical spondylotic myelopathy: a systematic review of the literature.

Authors:  Lifeng Lao; Guibin Zhong; Xinfeng Li; Lie Qian; Zude Liu
Journal:  J Orthop Surg Res       Date:  2013-12-01       Impact factor: 2.359

10.  The change of cervical sagittal parameters plays an important role in clinical outcomes of cervical spondylotic myelopathy after multi-level anterior cervical discectomy and fusion.

Authors:  Xi-Wen Fan; Zhi-Wei Wang; Xian-Da Gao; Wen-Yuan Ding; Da-Long Yang
Journal:  J Orthop Surg Res       Date:  2019-12-11       Impact factor: 2.359

View more
  2 in total

1.  Influence of fixed titanium plate position on the effectiveness of open-door laminoplasty for cervical spondylotic myelopathy.

Authors:  Fa-Jing Liu; Xiao-Kun Ding; Yi Chai; Su-Hong Qi; Peng-Fei Li
Journal:  J Orthop Surg Res       Date:  2022-06-03       Impact factor: 2.677

Review 2.  Smoking and degenerative spinal disease: A systematic review.

Authors:  Niharika Rajesh; Jigishaa Moudgil-Joshi; Chandrasekaran Kaliaperumal
Journal:  Brain Spine       Date:  2022-08-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.